Active, not recruitingPhase 1NCT02287311

Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)

Studying Non-Hodgkin lymphoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Baylor College of Medicine
Principal Investigator
Rayne H Rouce, MD, MD
Baylor College of Medicine
Intervention
MABEL CTLs(biological)
Enrollment
38 enrolled
Eligibility
All sexes
Timeline
2015 – 2029

Study locations (2)

Collaborators

Center for Cell and Gene Therapy, Baylor College of Medicine · The Methodist Hospital Research Institute

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02287311 on ClinicalTrials.gov

Other trials for Non-Hodgkin lymphoma

Additional recruiting or active studies for the same condition.

See all trials for Non-Hodgkin lymphoma →

← Back to all trials